Similar articles

• Roundtable discussion. Achieving more aggressive low-density lipoprotein cholesterol lowering.

  Hunninghake DB, McKenney JM, Gotto AM Jr, Mehta JL, Jones PH. Hunninghake DB, et al. Am J Manag Care. 2000 Nov;6(19 Suppl):S1008-16. Am J Manag Care. 2000. PMID: 11187369 No abstract available.
• Assessing the value and affordability of cholesterol reduction in the managed care setting.

  Gonzalez ER, Kannewurf BS. Gonzalez ER, et al. Am J Manag Care. 1998 Apr;4(4 Suppl):S226-33; quiz S234-5. Am J Manag Care. 1998. PMID: 10180344 No abstract available.
• The drug formulary decision-making process.

  Brehany J, Cohen P, Sax MJ. Brehany J, et al. Healthplan. 1999 May-Jun;40(3):85-92. Healthplan. 1999. PMID: 10538088 No abstract available.
• Improving cholesterol control in managed care populations.

  McKenney JM. McKenney JM. Am J Manag Care. 2000 Nov;6(19 Suppl):S997-1007. Am J Manag Care. 2000. PMID: 11187371 Review.
• Application of pharmacoeconomics to formulary decision making in managed care organizations.

  Suh DC, Okpara IR, Agnese WB, Toscani M. Suh DC, et al. Am J Manag Care. 2002 Feb;8(2):161-9. Am J Manag Care. 2002. PMID: 11858228 Review.